← SageRanks

Lynch on the BEL20

This ranking weighs PEG ×4, Revenue growth ×3, ROE ×2, Analyst upside ×1, Buy % ×1, and nothing else, across the 20 companies we track on the BEL20. 5 of them clear Lynch’s hard limits right now, and 3 cannot be judged because a required figure is missing.

Ranked highest by Lynch on this market right now, which is not the same list as the one that clears the limits above:

  1. argenx (ARGX.BR) · Healthcare · PEG 1.22 · Revenue growth 59.3% · ROE 24% · Analyst upside 17.8% · Buy % 87%
  2. UCB (UCB.BR) · Healthcare · PEG 1.10 · Revenue growth 22.5% · ROE 21% · Analyst upside 41.3% · Buy % 75%
  3. Aedifica (AED.BR) · Real Estate · Revenue growth 104.3% · ROE 12% · Analyst upside 26.4% · Buy % 80%
  4. Umicore (UMI.BR) · Industrials · PEG 2.62 · Revenue growth 60.1% · ROE 23% · Analyst upside 15.9% · Buy % 53%
  5. AB InBev (ABI.BR) · Consumer Defensive · PEG 1.64 · Revenue growth 11.0% · ROE 11% · Analyst upside 21.1% · Buy % 80%

From data as of 2026-09-11 03:00:56 UTC. Rebuilt every hour; the table above is live.

All 20 companies on the BEL20, ranked by Lynch, as text
  1. argenx (ARGX.BR) · PEG 1.22 · Revenue growth 59.3% · ROE 24% · Analyst upside 17.8% · Buy % 87%
  2. UCB (UCB.BR) · PEG 1.10 · Revenue growth 22.5% · ROE 21% · Analyst upside 41.3% · Buy % 75%
  3. Aedifica (AED.BR) · Revenue growth 104.3% · ROE 12% · Analyst upside 26.4% · Buy % 80%
  4. Umicore (UMI.BR) · PEG 2.62 · Revenue growth 60.1% · ROE 23% · Analyst upside 15.9% · Buy % 53%
  5. AB InBev (ABI.BR) · PEG 1.64 · Revenue growth 11.0% · ROE 11% · Analyst upside 21.1% · Buy % 80%
  6. Elia Group (ELI.BR) · PEG 2.82 · Revenue growth 18.0% · ROE 8% · Analyst upside 26.8% · Buy % 73%
  7. GBL (GBLB.BR) · PEG 0.52 · ROE -4% · Analyst upside 18.0% · Buy % 71%
  8. Sofina (SOF.BR) · PEG 3.37 · ROE 13% · Analyst upside 17.3% · Buy % 100%
  9. Melexis (MELE.BR) · PEG 1.69 · Revenue growth 2.6% · ROE 22% · Analyst upside 17.1% · Buy % 43%
  10. Syensqo (SYENS.BR) · PEG 0.29 · Revenue growth 4.1% · ROE -1% · Analyst upside 1.5% · Buy % 50%
  11. Ageas (AGS.BR) · PEG 6.39 · Revenue growth 27.5% · ROE 20% · Analyst upside -1.1% · Buy % 25%
  12. Montea (MONT.BR) · Revenue growth 11.1% · ROE 8% · Analyst upside 22.7% · Buy % 67%
  13. Lotus Bakeries (LOTB.BR) · PEG 9.38 · Revenue growth 14.0% · ROE 23% · Analyst upside 3.1% · Buy % 50%
  14. D'Ieteren (DIE.BR) · PEG 6.81 · Revenue growth 3.4% · Analyst upside 38.0% · Buy % 100%
  15. WDP (WDP.BR) · PEG 9.41 · Revenue growth 16.4% · ROE 8% · Analyst upside 27.8% · Buy % 73%
  16. Solvay (SOLB.BR) · PEG 0.29 · Revenue growth -5.9% · ROE 1% · Analyst upside -4.3% · Buy % 13%
  17. Colruyt (COLR.BR) · PEG 1.83 · Revenue growth 1.7% · ROE 10% · Analyst upside -8.2% · Buy % 30%
  18. Ackermans & van Haaren (ACKB.BR) · PEG 5.74 · Revenue growth -0.1% · ROE 12% · Analyst upside 16.3% · Buy % 57%
  19. Azelis (AZE.BR) · Revenue growth 0.3% · ROE 4% · Analyst upside 12.8% · Buy % 57%
  20. KBC (KBC.BR) · PEG 12.14 · Revenue growth 6.6% · ROE 14% · Analyst upside 0.2% · Buy % 32%